This inventor holds 1 USPTO granted patent. Top assignee: Interquim, S.a.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Santos Hernàndez Gallego: Innovator in Pharmaceutical Synthesis
Introduction
Santos Hernàndez Gallego is a notable inventor based in Cerdanyola del Vallès, Spain. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the preparation of intermediates for the synthesis of Dabigatran Etexilate. His work is essential for advancing the production of this important medication.
Latest Patents
Santos holds a patent for a process related to the preparation of intermediates for the synthesis of Dabigatran Etexilate. The patent details new processes that facilitate the industrial-scale preparation of synthesis intermediate products. Additionally, it introduces new crystalline forms of the intermediate products obtained through these processes.
Career Highlights
Santos is associated with Interquim, S.A., a company that specializes in the development and production of pharmaceutical intermediates. His work at Interquim has been pivotal in enhancing the efficiency and effectiveness of drug synthesis processes.
Collaborations
Santos has collaborated with notable colleagues, including Francisco Marquillas Olondriz and Marta Pomares Marco. Their teamwork has contributed to the successful development of innovative solutions in pharmaceutical synthesis.
Conclusion
Santos Hernàndez Gallego's contributions to the field of pharmaceutical synthesis exemplify the impact of innovation in healthcare. His patent for the synthesis of Dabigatran Etexilate intermediates showcases his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile